TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
TERT |
O14746
|
telomerase reverse transcriptase
|
Enzyme
|
0.99 |
0.374 |
0.846 |
MDM2 |
Q00987
|
MDM2 proto-oncogene
|
Nucleic acid binding
|
1.00 |
0.362 |
0.846 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
NRAS |
P01111
|
NRAS proto-oncogene, GTPase
|
Enzyme modulator
|
0.49 |
0.390 |
0.808 |
IGF2 |
P01344
|
insulin like growth factor 2
|
|
4.4E-02 |
0.390 |
0.885 |
MGMT |
P16455
|
O-6-methylguanine-DNA methyltransferase
|
|
1.2E-07 |
0.412 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CDK4 |
P11802
|
cyclin dependent kinase 4
|
Kinase
|
6.3E-02 |
0.412 |
0.808 |
MIR34A |
|
microRNA 34a
|
|
|
0.421 |
0.846 |
S100A9 |
P06702
|
S100 calcium binding protein A9
|
Calcium-binding protein
|
0.48 |
0.433 |
0.885 |
IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
S100A4 |
P26447
|
S100 calcium binding protein A4
|
Calcium-binding protein
|
6.2E-03 |
0.448 |
0.769 |
EDNRB |
P24530
|
endothelin receptor type B
|
G-protein coupled receptor
|
9.2E-03 |
0.470 |
0.846 |
BAP1 |
Q92560
|
BRCA1 associated protein 1
|
Enzyme
|
0.99 |
0.454 |
0.731 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
SUB1 |
P53999
|
SUB1 regulator of transcription
|
|
0.89 |
0.465 |
0.846 |